Literature DB >> 24412615

Proatherogenic conditions promote autoimmune T helper 17 cell responses in vivo.

Hoyong Lim1, Young Uk Kim2, Hua Sun3, Joyce H Lee1, Joseph M Reynolds4, Shino Hanabuchi4, Huaizhu Wu5, Ba-Bie Teng6, Yeonseok Chung7.   

Abstract

Patients with systemic autoimmune diseases show increased incidence of atherosclerosis. However, the contribution of proatherogenic factors to autoimmunity remains unclear. We found that atherogenic mice (herein referred to as LDb mice) exhibited increased serum interleukin-17, which was associated with increased numbers of T helper 17 (Th17) cells in secondary lymphoid organs. The environment within LDb mice was substantially favorable for Th17 cell polarization of autoreactive T cells during homeostatic proliferation, which was considerably inhibited by antibodies directed against oxidized low-density lipoprotein (oxLDL). Moreover, the uptake of oxLDL induced dendritic-cell-mediated Th17 cell polarization by triggering IL-6 production in a process dependent on TLR4, CD36, and MyD88. Furthermore, self-reactive CD4(+) T cells that expanded in the presence of oxLDL induced more profound experimental autoimmune encephalomyelitis. These findings demonstrate that proatherogenic factors promote the polarization and inflammatory function of autoimmune Th17 cells, which could be critical for the pathogenesis of atherosclerosis and other related autoimmune diseases.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24412615      PMCID: PMC3955722          DOI: 10.1016/j.immuni.2013.11.021

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  48 in total

1.  Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients.

Authors:  M Janabi; S Yamashita; K Hirano; N Sakai; H Hiraoka; K Matsumoto; Z Zhang; S Nozaki; Y Matsuzawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-08       Impact factor: 8.311

2.  Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques.

Authors:  Frank Tacke; David Alvarez; Theodore J Kaplan; Claudia Jakubzick; Rainer Spanbroek; Jaime Llodra; Alexandre Garin; Jianhua Liu; Matthias Mack; Nico van Rooijen; Sergio A Lira; Andreas J Habenicht; Gwendalyn J Randolph
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

3.  Interferon-gamma elicits arteriosclerosis in the absence of leukocytes.

Authors:  G Tellides; D A Tereb; N C Kirkiles-Smith; R W Kim; J H Wilson; J S Schechner; M I Lorber; J S Pober
Journal:  Nature       Date:  2000-01-13       Impact factor: 49.962

4.  TLR4 links innate immunity and fatty acid-induced insulin resistance.

Authors:  Hang Shi; Maia V Kokoeva; Karen Inouye; Iphigenia Tzameli; Huali Yin; Jeffrey S Flier
Journal:  J Clin Invest       Date:  2006-10-19       Impact factor: 14.808

5.  IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.

Authors:  S Gupta; A M Pablo; X c Jiang; N Wang; A R Tall; C Schindler
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

6.  The role of oxidized low-density lipoprotein in breaking peripheral Th17/Treg balance in patients with acute coronary syndrome.

Authors:  Qing Li; Yi Wang; Ke Chen; Qing Zhou; Wei Wei; Yiping Wang; Yuan Wang
Journal:  Biochem Biophys Res Commun       Date:  2010-03-17       Impact factor: 3.575

7.  Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.

Authors:  Mary J Roman; Beth-Ann Shanker; Adrienne Davis; Michael D Lockshin; Lisa Sammaritano; Ronit Simantov; Mary K Crow; Joseph E Schwartz; Stephen A Paget; Richard B Devereux; Jane E Salmon
Journal:  N Engl J Med       Date:  2003-12-18       Impact factor: 91.245

8.  Hepatic gene expression profiling reveals perturbed calcium signaling in a mouse model lacking both LDL receptor and Apobec1 genes.

Authors:  Ranjan Dutta; Uma Singh; Tong-Bin Li; Myriam Fornage; Ba-Bie Teng
Journal:  Atherosclerosis       Date:  2003-07       Impact factor: 5.162

9.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

Authors:  Marc Veldhoen; Richard J Hocking; Christopher J Atkins; Richard M Locksley; Brigitta Stockinger
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

10.  Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s.

Authors:  N Goodson; J Marks; M Lunt; D Symmons
Journal:  Ann Rheum Dis       Date:  2005-04-20       Impact factor: 19.103

View more
  51 in total

Review 1.  How Oxidized Low-Density Lipoprotein Activates Inflammatory Responses.

Authors:  Jillian P Rhoads; Amy S Major
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

Review 2.  Autoimmunity and organ damage in systemic lupus erythematosus.

Authors:  George C Tsokos
Journal:  Nat Immunol       Date:  2020-05-04       Impact factor: 25.606

Review 3.  Progress and prospect of mesenchymal stem cell-based therapy in atherosclerosis.

Authors:  Ximei Zhang; Feng Huang; Yanming Chen; Xiaoxian Qian; Song Guo Zheng
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

4.  Loss of Regulatory Immune Function in Coronary Artery Disease Patients from the Indian Population.

Authors:  Thiruvelselvan Ponnusamy; Srikanth Komarulu Venkatachala; Manjunatha Ramanujappa; Lakshmi Mundkur
Journal:  J Cardiovasc Transl Res       Date:  2019-02-27       Impact factor: 4.132

5.  Endothelial inflammatory transcriptional responses to an altered plasma exposome following inhalation of diesel emissions.

Authors:  Jonathan C Schisler; Sarah M Ronnebaum; Michael Madden; Meghan Channell; Matthew Campen; Monte S Willis
Journal:  Inhal Toxicol       Date:  2015-05-05       Impact factor: 2.724

Review 6.  Extracellular vesicles as mediators of vascular inflammation in kidney disease.

Authors:  Alexandra Helmke; Sibylle von Vietinghoff
Journal:  World J Nephrol       Date:  2016-03-06

7.  Hyperlipidemia Alters Regulatory T Cell Function and Promotes Resistance to Tolerance Induction Through Costimulatory Molecule Blockade.

Authors:  J Bagley; J Yuan; A Chandrakar; J Iacomini
Journal:  Am J Transplant       Date:  2015-06-16       Impact factor: 8.086

8.  Hyperlipidemia Promotes Anti-Donor Th17 Responses That Accelerate Allograft Rejection.

Authors:  J Yuan; J Bagley; J Iacomini
Journal:  Am J Transplant       Date:  2015-06-16       Impact factor: 8.086

9.  CXCR6 regulates the recruitment of pro-inflammatory IL-17A-producing T cells into atherosclerotic aortas.

Authors:  Matthew J Butcher; Chih-I Wu; Tayab Waseem; Elena V Galkina
Journal:  Int Immunol       Date:  2015-11-27       Impact factor: 4.823

10.  New insights into immunomodulation via overexpressing lipoic acid synthase as a therapeutic potential to reduce atherosclerosis.

Authors:  Shaomin Tian; Jun Nakamura; Sylvia Hiller; Stephen Simington; Darcy W Holley; Roberto Mota; Monte S Willis; Scott J Bultman; J Christopher Luft; Joseph M DeSimone; Zhenquan Jia; Nobuyo Maeda; Xianwen Yi
Journal:  Vascul Pharmacol       Date:  2020-08-01       Impact factor: 5.773

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.